Answers are grounded in this paper and cite their sources.
Metformin monotherapy and combination therapy with metformin and sulfonylurea are well tolerated and improve glycemic control and lipid concentrations in patients with NIDDM whose diabetes is poorly controlled with diet or sulfonylurea therapy alone.
No takes yet. Share an insight, caveat, or question.
DeFronzo et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: